News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

Corporate News

Staff Style

Home page

Angel Rescue Escorts Love | Keyuan Pharmaceutical & Linuo Pharmaceutical donate lovingly to support the development of grassroots medical and health care in Shanghe County!

On August 12, the 2023 "Angel Health Assistance Helps Rural Revitalization" large-scale public welfare series of activities and the Jinan City Health System's 100-day campaign to solve the urgent and anxious problems of the masses and four major public welfare projects to benefit the people were held in Shanghe County.

2023

A total of Xipu with the same frequency | Keyuan Pharmaceutical & Linuo Pharmaceutical made a wonderful appearance at the 2023 Xipu Conference!

On August 10th, the 2023 Health Industry (International) Ecological Conference (hereinafter referred to as Xipu Conference) was grandly opened in Boao, Hainan, China. As an influential and well-known annual event in my country's health industry, the Xipu Conference has been successfully held for fifteen years and has become an important benchmark for predicting the future of the industry and identifying industry trends.

2023

Xipu Resonance Gathering in Boao | Keyuan Pharmaceutical & Linuo Pharmaceutical will meet you at J12 of 2023 Syrp Event!

The 2023 Xipu Conference will be held in Boao, Hainan from August 9th to 14th. The theme of this conference is "Dual Synergy Reshaping the Industry—Opening a New Era of Personal Health Subject Responsibility", with the purpose of "Leading Industrial Innovation and Integration" and the core labels of "Cooperation, Innovation, Technology, R&D, and Capital" , to create a grand event for the health industry, to provide forward-looking and systematic exchanges of ideas and information for the industry, and to connect and cooperate with multiple resources from strategy to strategy.

2023

Improve quality and reduce costs to expand the market and work together to forge ahead | Keyuan Pharmaceutical & Linuo Pharmaceutical held a semi-annual work meeting!

From July 28th to 29th, Shandong Keyuan Pharmaceutical Co., Ltd. and Shandong Linuo Pharmaceutical Co., Ltd. held the 2023 semi-annual policy supervision work meeting to review and summarize the experience and achievements in the first half of the year, deploy key tasks in the second half of the year, and mobilize all cadres and employees to take responsibility for the direction Forge ahead under pressure, anchor the goals and tasks for the second half of the year, gather strength to make breakthroughs, and scale new heights.

2023

Take advantage of the victory and pursue a comprehensive breakthrough|Linuo Pharmaceutical holds a semi-annual marketing conference!

From July 17th to 18th, Shandong Linuo Pharmaceutical Co., Ltd. held the 2023 semi-annual marketing conference. The conference reviews and summarizes the operating results in the first half of the year, deploys and arranges key tasks for the second half of the year, and focuses on the achievement of targets in the second half of the year, unifies thinking, takes responsibility and moves forward, breaks through under pressure, and launches an impact towards higher tasks, so as to continue to contribute to the high-quality and rapid development of Linuo Pharmaceutical.

2023

Dingxin peers, integration and innovation | The 2023 Keyuan Pharmaceutical & Linuo Pharmaceutical team building activities have come to a successful conclusion!

In order to create a relaxed working atmosphere and strengthen the degree of communication and integration between Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ) and its subsidiary Shandong Linuo Pharmaceutical Co., Ltd., the two companies jointly cooperated on July 14-15 Host team building events.

2023

< 1...20 21 22...25 >

TEL：+86-531-88729642

E-mail：lnyybgs@lnphar.com

ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China